NDC 72934-2093

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%

Hyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.05%

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Tazarotene; Hyaluronate Sodium.

Product ID72934-2093_8879f8d5-e9c7-f749-e053-2a95a90a8af5
NDC72934-2093
Product TypeHuman Prescription Drug
Proprietary NameHYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%
Generic NameHyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.05%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-10
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameTAZAROTENE; HYALURONATE SODIUM
Active Ingredient Strength0 g/100g; g/100g
Pharm ClassesRetinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2093-2

30 g in 1 BOTTLE, PUMP (72934-2093-2)
Marketing Start Date2019-05-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2093-2 [72934209302]

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05% CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-10

Drug Details

Active Ingredients

IngredientStrength
TAZAROTENE.05 g/100g

Pharmacological Class

  • Retinoid [EPC]
  • Retinoids [CS]
  • Retinoid [EPC]
  • Retinoids [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.